Novavax working on combination vaccine for Covid-19 and flu

A combination flu and Covid-19 vaccine has passed the test in animals and can now move on to trials in humans. — AFP

American biotech firm Novavax said on May 10 (2021) that it had positive results from preclinical studies of a shot combining its influenza and Covid-19 vaccine candidates.

The study, now on a preprint server and awaiting peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters.